company background image
GHTI

G-H-3 International OTCPK:GHTI Stock Report

Last Price

US$0.000001

Market Cap

US$0

7D

0%

1Y

n/a

Updated

25 Apr, 2024

Data

Company Financials

GHTI Stock Overview

G-H-3 International Inc. develops products for addressing factors, which cause aging and deterioration in the body.

GHTI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

G-H-3 International Inc. Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for G-H-3 International
Historical stock prices
Current Share PriceUS$0.000001
52 Week HighUS$0.000001
52 Week LowUS$0.000001
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-99.60%
5 Year Changen/a
Change since IPO-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

GHTIUS PharmaceuticalsUS Market
7D0%-0.6%1.0%
1Yn/a10.6%21.9%

Return vs Industry: Insufficient data to determine how GHTI performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how GHTI performed against the US Market.

Price Volatility

Is GHTI's price volatile compared to industry and market?
GHTI volatility
GHTI Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: GHTI has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GHTI's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aFlo Ternesn/a

G-H-3 International Inc. develops products for addressing factors, which cause aging and deterioration in the body. Its product, G-H-3-Plus is a comprehensive protocol that promotes anti-aging, treat chronic disease, and improve health and vitality. The G-H-3-Plus protocol includes a combination of intravenous treatment, intramuscular injections, prescriptions, vitamins, and skin care products.

G-H-3 International Inc. Fundamentals Summary

How do G-H-3 International's earnings and revenue compare to its market cap?
GHTI fundamental statistics
Market capn/a
Earnings (TTM)US$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GHTI income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$0
EarningsUS$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did GHTI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.